Additional Resistance to any Fluoroquinolones among Multidrug-resistant Mycobacterium tuberculosis Isolates from North Coastal Andhra Pradesh, India

Additional Resistance to any Fluoroquinolones among Multidrug-resistant Mycobacterium tuberculosis Isolates from North Coastal Andhra Pradesh, India

Fluoroquinolones (FQ) are integral part of multidrug resistant/rifampicin resistant tuberculosis (MDR-TB/RR TB) treatment regimens. FQ resistance in MDR-TB lead to narrower treatment options and poor treatment outcomes. Hence proportion of FQ resistance among MDR-TB and cross-resistance among FQ in...

Full description

Bibliographic Details
Main Authors:	Kancharla Suresh, Yapadinna Vimala, Nitin Mohan, Indugula Jyothi Padmaja
Format:	Article
Language:	English
Published:	Journal of Pure and Applied Microbiology 2021-03-01
Series:	Journal of Pure and Applied Microbiology
Subjects:	multidrug-resistant tuberculosis fluoroquinolones mgit 960 cross-resistance
Online Access:	https://microbiologyjournal.org/additional-resistance-to-any-fluoroquinolones-among-multidrug-resistant-mycobacterium-tuberculosis-isolates-from-north-coastal-andhra-pradesh-india/

Similar Items

High moxifloxacin cross-resistance levels among “newly identified” ofloxacin-resistant multidrug-resistant tuberculosis patients from South India: A ticking bomb or a tricky challenge?
by: Praveen Sanker, et al.
Published: (2017-01-01)

A RETROSPECTIVE STUDY ON MULTI DRUG RESISTANT TUBERCULOSIS IN A TERTIARY CARE HOSPITAL: AN ALARMING THREAT OF CONCERN.
by: Kumari Seema, et al.
Published: (2023-06-01)

Impact of Anti-Tuberculosis Drug Use on Treatment Outcomes in Patients with Pulmonary Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: A Nationwide Retrospective Cohort Study with Propensity Score Matching
by: Hongjo Choi, et al.
Published: (2023-07-01)

Trend of multidrug and fluoroquinolone resistance in Mycobacterium tuberculosis isolates from 2010 to 2014 in Korea: a multicenter study
by: Hyeonseok Kim, et al.
Published: (2019-03-01)

Transmission of fluoroquinolones resistance among multidrug-resistant tuberculosis in Shanghai, China: a retrospective population-based genomic epidemiology study
by: Minjuan Li, et al.
Published: (2024-12-01)

Fluoroquinolone resistance in urinary tract infections: Epidemiology, mechanisms of action and management strategies
by: Daryl Thompson, et al.
Published: (2024-01-01)

Snapshot of <i>Mycobacterium tuberculosis</i> Phylogenetics from an Indian State of Arunachal Pradesh Bordering China
by: Shiv kumar Rashmi Mudliar, et al.
Published: (2022-01-01)

Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline
by: Béla Kocsis, et al.
Published: (2021-12-01)

Laboratory Diagnosis of Tuberculous Meningitis – Is There a Scope for Further Improvement?
by: Rajeev Thakur, et al.
Published: (2010-01-01)

Phenotypic and genotypic drug sensitivity profiles of Mycobacterium tuberculosis infection and associated factors in northeastern Ethiopia
by: Fikru Gashaw, et al.
Published: (2021-03-01)

Spread of multidrug resistance among Ureaplasma serovars, Tunisia
by: Safa Boujemaa, et al.
Published: (2020-01-01)

Use of Bactec MGIT 960 ParaTB system for the diagnosis of bovine paratuberculosis
by: B J TRANGADIA, et al.
Published: (2016-01-01)

High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region
by: Viola Dreyer, et al.
Published: (2022-08-01)

Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa
by: Nontuthuko E. Maningi, et al.
Published: (2017-12-01)

Are WHO approved nucleic acid amplification tests causing large-scale “false identification” of rifampicin-resistant tuberculosis?: Programmatic experience from south india
by: Praveen Sanker, et al.
Published: (2017-01-01)

Fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Pakistan 2010–2014: Implications for disease control
by: Kausar Jabeen, et al.
Published: (2015-01-01)

Emerging Mechanisms of Fluoroquinolone Resistance
by: David C. Hooper
Published: (2001-04-01)

Potential Role of Proteasome Accessory Factor-C in Resistance against Second Line Drugs in Mycobacteria
by: Apoorva Narain, et al.
Published: (2020-12-01)

Global Evolution of Pathogenic Bacteria With Extensive Use of Fluoroquinolone Agents
by: Miklos Fuzi, et al.
Published: (2020-02-01)

Urinary tract infections: resistance to fluoroquinolones in E. coli
by: Gabriella Candelieri, et al.
Published: (2009-12-01)

Antimicrobial susceptibility and molecular characteristics of beta-lactam- and fluoroquinolone-resistant E. coli from human clinical samples in Nigeria
by: E. Egwu, et al.
Published: (2023-09-01)

The Comparison of the BBL-Mycobacteria Growth Indicator Tube (MGIT) with Löwenstein-Jensen Culture Media and Evaluation of the Resistance of the Isolated Strains Against Four Major Drugs
by: Bekir KOCAZEYBEK
Published: (2002-06-01)

Resistance rate and mechanism of ureaplasma urealyticum to fluoroquinolones in infertile patients
by: YUAN Yaling1, et al.
Published: (2022-07-01)

Antibiotypes and genetic characteristics of fluoroquinolone- and beta-lactam-resistant Escherichia coli isolated from food-producing animals
by: E. Egwu, et al.
Published: (2024-01-01)

Typhoidal Salmonella and Emerging Resistance in Outbreak Proportions
by: Bindu Poonia, et al.
Published: (2018-04-01)

Fluoroquinolone resistance: relation between drug use and evolution of resistance in some Units of the “San Bassiano” hospital from 2007 to 2008
by: Claudia Mascotto, et al.
Published: (2010-06-01)

An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial
by: Tara C. Bouton, et al.
Published: (2017-11-01)

Evaluation of Various Risk Factors for the Emergence of Resistance to Fluoroquinolones
by: İlker İnanç BALKAN, et al.
Published: (2005-06-01)

Dynamics of Staphylococcus Aureus Antibiotic Resistance to Fluoroquinolones in Vitro
by: Chopey I., et al.
Published: (2018-06-01)

Fluoroquinolone-resistant tuberculosis: implications in settings with weak healthcare systems
by: Kauser Jabeen, et al.
Published: (2015-03-01)

Detection of multidrug resistance and associated genes among <em>Salmonella</em> species from enteric fever cases
by: S. Elumalai, et al.
Published: (2022-06-01)

Fluoroquinolone Prophylaxis Against Febrile Neutropenia in Areas With High Fluoroquinolone Resistance—An Asian Perspective
by: Esther Shu-Ting Ng, et al.
Published: (2010-09-01)

Emergence of fluoroquinolone resistance among drug resistant tuberculosis patients at a tertiary care facility in Karachi, Pakistan
by: Syed Mohammad Asad Zaidi, et al.
Published: (2017-07-01)

Identification and Characterization of Fluoroquinolone Non-susceptible Streptococcus pyogenes Clones Harboring Tetracycline and Macrolide Resistance in Shanghai, China
by: Yinfang Shen, et al.
Published: (2018-03-01)

First report of molecular detection of fluoroquinolone resistance-associated <it>gyrA </it>mutations in multidrug-resistant clinical <it>Mycobacterium tuberculosis </it>isolates in Kuwait
by: Ahmad Suhail, et al.
Published: (2011-04-01)

Assessment of diagnostic accuracy of Gene Xpert MTB/RIF in diagnosis of suspected retreatment pulmonary tuberculosis patients
by: Takwa E. Meawed, et al.
Published: (2016-07-01)

Automated diagnosis of Tuberculosis: A review of advancements
by: EO Shobowale, et al.
Published: (2015-06-01)

Fluoroquinolones Hybrid Molecules as Promising Antibacterial Agents in the Fight against Antibacterial Resistance
by: Ioana-Andreea Lungu, et al.
Published: (2022-08-01)

Characterization of Fluoroquinolone-Resistant and Multidrug-Resistant Mycobacterium tuberculosis Isolates Using Whole-Genome Sequencing in Tianjin, China
by: Wang Z, et al.
Published: (2022-04-01)

Factors Influencing Fluoroquinolone Resistance
by: Daniel F. Sahm, et al.
Published: (2003-12-01)